nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Anal cancer screening
|
Palefsky, Joel |
|
2012 |
13 |
7 |
p. e279-e280 nvt p. |
artikel |
2 |
Anal cancer screening
|
Barroso, Luis F |
|
2012 |
13 |
7 |
p. e278-e279 nvt p. |
artikel |
3 |
Anal cancer screening – Authors' reply
|
Grulich, Andrew E |
|
2012 |
13 |
7 |
p. e280- 1 p. |
artikel |
4 |
Are patients counting the cost of the economic downturn?
|
The Lancet Oncology, |
|
2012 |
13 |
7 |
p. 649- 1 p. |
artikel |
5 |
2012 ASCO Annual Meeting
|
Brierley, Rob |
|
2012 |
13 |
7 |
p. 665-666 2 p. |
artikel |
6 |
ASTRO presidential nominees chart priorities for future
|
Furlow, Bryant |
|
2012 |
13 |
7 |
p. 662- 1 p. |
artikel |
7 |
Beyond targeting malignant B cells
|
Ansell, Stephen M |
|
2012 |
13 |
7 |
p. 657-658 2 p. |
artikel |
8 |
Bisphosphonates in early breast cancer
|
Dubsky, Peter |
|
2012 |
13 |
7 |
p. 660-661 2 p. |
artikel |
9 |
Cancer charities kindle Olympic spirit
|
Jouret, Jill |
|
2012 |
13 |
7 |
p. 667- 1 p. |
artikel |
10 |
Carcinogenicity of diesel-engine and gasoline-engine exhausts and some nitroarenes
|
Benbrahim-Tallaa, Lamia |
|
2012 |
13 |
7 |
p. 663-664 2 p. |
artikel |
11 |
Chromosome 8q gain in clear-cell renal-cell carcinoma
|
Sharma, Sharan Prakash |
|
2012 |
13 |
7 |
p. e289- 1 p. |
artikel |
12 |
Circulating tumour cells as biomarkers in early breast cancer
|
Krell, Jonathan |
|
2012 |
13 |
7 |
p. 653-654 2 p. |
artikel |
13 |
Circulating tumour cells in non-metastatic breast cancer: a prospective study
|
Lucci, Anthony |
|
2012 |
13 |
7 |
p. 688-695 8 p. |
artikel |
14 |
Clinical trial design in head and neck cancer: what has the oncologist learned?
|
Adelstein, David J |
|
2012 |
13 |
7 |
p. e318-e323 nvt p. |
artikel |
15 |
Combination chemotherapy for adrenocortical carcinoma
|
Senior, Kathryn |
|
2012 |
13 |
7 |
p. e290- 1 p. |
artikel |
16 |
Conservative mastectomy: extending the idea of breast conservation
|
Veronesi, Umberto |
|
2012 |
13 |
7 |
p. e311-e317 nvt p. |
artikel |
17 |
Correction to Lancet Oncol 2012; 13: 696
|
|
|
2012 |
13 |
7 |
p. e285- 1 p. |
artikel |
18 |
Correction to Lancet Oncol 2012; 13: 559
|
|
|
2012 |
13 |
7 |
p. e285- 1 p. |
artikel |
19 |
FDA provides fastest drug approval
|
Gilbert, Judith A |
|
2012 |
13 |
7 |
p. e287- 1 p. |
artikel |
20 |
Focal HIFU for prostate cancer
|
Lazzeri, Massimo |
|
2012 |
13 |
7 |
p. e281-e282 nvt p. |
artikel |
21 |
Focal HIFU for prostate cancer
|
Challacombe, Ben |
|
2012 |
13 |
7 |
p. e283-e284 nvt p. |
artikel |
22 |
Focal HIFU for prostate cancer
|
Jereczek-Fossa, Barbara Alicja |
|
2012 |
13 |
7 |
p. e280-e281 nvt p. |
artikel |
23 |
Focal HIFU for prostate cancer
|
Créhange, Gilles |
|
2012 |
13 |
7 |
p. e282-e283 nvt p. |
artikel |
24 |
Focal HIFU for prostate cancer – Authors' reply
|
Ahmed, Hashim U |
|
2012 |
13 |
7 |
p. e284- 1 p. |
artikel |
25 |
Immunotherapies for non-small-cell lung cancer and mesothelioma
|
Thomas, Anish |
|
2012 |
13 |
7 |
p. e301-e310 nvt p. |
artikel |
26 |
Ipilimumab in patients with melanoma and brain metastases
|
Nieder, Carsten |
|
2012 |
13 |
7 |
p. e277- 1 p. |
artikel |
27 |
Ipilimumab in patients with melanoma and brain metastases – Authors' reply
|
Margolin, Kim |
|
2012 |
13 |
7 |
p. e277-e278 nvt p. |
artikel |
28 |
Lenalidomide in combination with rituximab for patients with relapsed or refractory mantle-cell lymphoma: a phase 1/2 clinical trial
|
Wang, Michael |
|
2012 |
13 |
7 |
p. 716-723 8 p. |
artikel |
29 |
My Cancer Genome: a unified genomics and clinical trial portal
|
Swanton, Charles |
|
2012 |
13 |
7 |
p. 668-669 2 p. |
artikel |
30 |
New treatment option for untreated AML and MDS
|
Sharma, Sharan Prakash |
|
2012 |
13 |
7 |
p. e287- 1 p. |
artikel |
31 |
NICE: opioids should be first-line for cancer pain
|
Senior, Kathryn |
|
2012 |
13 |
7 |
p. e289- 1 p. |
artikel |
32 |
Oral clodronate for adjuvant treatment of operable breast cancer (National Surgical Adjuvant Breast and Bowel Project protocol B-34): a multicentre, placebo-controlled, randomised trial
|
Paterson, Alexander HG |
|
2012 |
13 |
7 |
p. 734-742 9 p. |
artikel |
33 |
Pancreatic cancer vaccine shows promise
|
Tanday, Sanjay |
|
2012 |
13 |
7 |
p. e288- 1 p. |
artikel |
34 |
Pixantrone: a new agent for relapsed aggressive lymphomas
|
Cabanillas, Fernando |
|
2012 |
13 |
7 |
p. 654-656 3 p. |
artikel |
35 |
Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: a phase 3, multicentre, open-label, randomised trial
|
Pettengell, Ruth |
|
2012 |
13 |
7 |
p. 696-706 11 p. |
artikel |
36 |
Predictive value of loci in VEGF pathway genes in bevacizumab treatment
|
Moroni, Mauro |
|
2012 |
13 |
7 |
p. 659-660 2 p. |
artikel |
37 |
Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial
|
Rödel, Claus |
|
2012 |
13 |
7 |
p. 679-687 9 p. |
artikel |
38 |
Radiotherapy for head and neck tumours in 2012 and beyond: conformal, tailored, and adaptive?
|
Grégoire, Vincent |
|
2012 |
13 |
7 |
p. e292-e300 nvt p. |
artikel |
39 |
Raising a glass of red wine against cancer, or not?
|
Frampton, Adam E |
|
2012 |
13 |
7 |
p. 669-670 2 p. |
artikel |
40 |
Rectal cancer—the times they are a-changing
|
Glynne-Jones, Robert |
|
2012 |
13 |
7 |
p. 651-653 3 p. |
artikel |
41 |
Studies show link between sleep apnoea and cancer
|
Bennet, Neil |
|
2012 |
13 |
7 |
p. e286- 1 p. |
artikel |
42 |
Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial
|
Wick, Wolfgang |
|
2012 |
13 |
7 |
p. 707-715 9 p. |
artikel |
43 |
Thoracic radiotherapy with or without daily low-dose carboplatin in elderly patients with non-small-cell lung cancer: a randomised, controlled, phase 3 trial by the Japan Clinical Oncology Group (JCOG0301)
|
Atagi, Shinji |
|
2012 |
13 |
7 |
p. 671-678 8 p. |
artikel |
44 |
Treating cancer as a game
|
Christodoulou, Mario |
|
2012 |
13 |
7 |
p. 668- 1 p. |
artikel |
45 |
Treating elderly patients with stage III NSCLC
|
Wisnivesky, Juan P |
|
2012 |
13 |
7 |
p. 650-651 2 p. |
artikel |
46 |
Treatment of elderly patients with glioblastoma
|
Reardon, David A |
|
2012 |
13 |
7 |
p. 656-657 2 p. |
artikel |
47 |
Tuberculosis linked to lung cancer mortality in the elderly
|
Dehnel, Tim |
|
2012 |
13 |
7 |
p. e286- 1 p. |
artikel |
48 |
UK experts say PIP breast implants are not carcinogenic
|
Tanday, Sanjay |
|
2012 |
13 |
7 |
p. e291- 1 p. |
artikel |
49 |
UK pilot of HPV primary screening for cervical cancer
|
Bennet, Neil |
|
2012 |
13 |
7 |
p. e288- 1 p. |
artikel |
50 |
US cancer survivors to number 18 million by 2022
|
Bennet, Neil |
|
2012 |
13 |
7 |
p. e291- 1 p. |
artikel |
51 |
VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials
|
Lambrechts, Diether |
|
2012 |
13 |
7 |
p. 724-733 10 p. |
artikel |
52 |
Vismodegib effective against advanced basal-cell carcinoma
|
Wilkinson, Emma |
|
2012 |
13 |
7 |
p. e290- 1 p. |
artikel |
53 |
Voices from the front: July
|
Mastrianni, David M |
|
2012 |
13 |
7 |
p. 670- 1 p. |
artikel |
54 |
WITHDRAWN: Cancer detection and primary care…revisited
|
The Lancet Oncology, |
|
2012 |
13 |
7 |
p. I- 1 p. |
artikel |